Columbus Circle Investors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Columbus Circle Investors’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$8M	Sell	36,439 -31,009	-46%	-$6.7M	0.35%	99
2020 Q3	$11.2M	Sell	67,448 -7,378	-10%	-$1.01M	0.49%	80
2020 Q2	$8.54M	Buy	74,826 +26,483	+55%	+$2.57M	0.34%	97
2020 Q1	$3.72M	Sell	48,343 -7,061	-13%	-$633K	0.2%	125
2019 Q4	$7.14M	Sell	55,404 -979	-2%	-$94.4K	0.31%	107
2019 Q3	$4.39M	Buy	56,383 +49,595	+731%	+$4.65M	0.16%	133
2019 Q2	$699K	Buy	+6,788	New	+$528K	0.02%	156
2015 Q4	–	Sell	-305,780	Closed	-$10.5M	–	315
2015 Q3	$10.5M	Buy	+305,780	New	+$9.24M	0.09%	184

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Columbus Circle Investors's MRTX Position: Q4 2020 in Review

Columbus Circle Investors reduced its Mirati Therapeutics, Inc. Common Stock (MRTX) stake by 46% in Q4 2020, selling an estimated $6.7M and leaving 36,439 shares worth $8M. The position accounts for 0.35% of the portfolio, ranked #99.

Columbus Circle Investors first reported a position in MRTX in Q3 2015 and has held it in 8 quarters since. The position peaked at $11.2M in Q3 2020. 284 funds tracked by Wall St. Rank hold MRTX as of Q4 2020.

Columbus Circle Investors held 36,439 shares of Mirati Therapeutics, Inc. Common Stock worth $8M as of Q4 2020.
Columbus Circle Investors sold 31,009 Mirati Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $6.7M.
Mirati Therapeutics, Inc. Common Stock made up 0.35% of Columbus Circle Investors's portfolio in Q4 2020, its #99 holding.
Columbus Circle Investors first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2015 and has held it in 8 quarters since.
Columbus Circle Investors's Mirati Therapeutics, Inc. Common Stock position peaked at $11.2M in Q3 2020.
284 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.